- Home
- INM vs QNRX Comparison
INM vs QNRX Comparison
Compare INM & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- QNRX
- Stock Information
- Founded
- INM 1981
- QNRX 2018
- Country
- INM Canada
- QNRX United States
- Employees
- INM N/A
- QNRX N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- QNRX Medical/Dental Instruments
- Sector
- INM Health Care
- QNRX Health Care
- Exchange
- INM Nasdaq
- QNRX Nasdaq
- Market Cap
- INM 3.2M
- QNRX 3.3M
- IPO Year
- INM N/A
- QNRX N/A
- Fundamental
- Price
- INM $2.87
- QNRX $8.82
- Analyst Decision
- INM
- QNRX
- Analyst Count
- INM 0
- QNRX 0
- Target Price
- INM N/A
- QNRX N/A
- AVG Volume (30 Days)
- INM 4.1M
- QNRX 522.9K
- Earning Date
- INM 05-12-2025
- QNRX 05-13-2025
- Dividend Yield
- INM N/A
- QNRX N/A
- EPS Growth
- INM N/A
- QNRX N/A
- EPS
- INM N/A
- QNRX N/A
- Revenue
- INM $4,920,990.00
- QNRX N/A
- Revenue This Year
- INM N/A
- QNRX N/A
- Revenue Next Year
- INM N/A
- QNRX N/A
- P/E Ratio
- INM N/A
- QNRX N/A
- Revenue Growth
- INM N/A
- QNRX N/A
- 52 Week Low
- INM $1.72
- QNRX $5.01
- 52 Week High
- INM $15.70
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- INM 50.24
- QNRX 57.93
- Support Level
- INM $2.74
- QNRX $8.67
- Resistance Level
- INM $3.45
- QNRX $9.30
- Average True Range (ATR)
- INM 0.70
- QNRX 0.62
- MACD
- INM 0.03
- QNRX 0.03
- Stochastic Oscillator
- INM 9.40
- QNRX 56.63
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.